Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

ProPhase Labs, Inc. Common Stock (DE) (PRPH)
ProPhase Labs, Inc. Common Stock (DE)
XNAS:PRPH
0.22
23.20%

Ask
$0.24 - 1,500.00
Bid
$0.19 - 3,000.00
Low
$0.18
High
$0.21
Open
$0.19
Prev Close
$0.18
52W High
0.93
52W Low
0.16
Volume
1776741
Avg Vol (3m)
1446704.9
Float
42489251.72
Chart
TendieTensor AI Analysis

Company
Asset Type: Common Stock
SIC Code: 2834
Sector: Health Technology
Industry: Pharmaceuticals: Other
Date Listed: 02/01/1995
Primary Exchange: XNAS

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Phone: (215) 345-0919
Address: 711 Stewart Ave, Suite 200
Address 2: Garden City
City: New York
State: NY
Postal Code: 11530
TendieTensor AI Analyst Recommendation:
Fundamentals
Total Employees:
96
P/E (TTM)
-0.140000
P/B (TTM)
1.264830
Round Lot
100
Composit FIGI
BBG000F5PGF2
Share Class FIGI
BBG001S9HYF8
Share Class Shares Outstanding
41.54M
Weighted Shares Outstanding
41.54M

Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
Days to Cover
Higher = harder to cover
Short Interest Δ
Prev: —
Short Volume Ratio (Today)
5D avg:
Squeeze Score (0–100)
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own PRPH. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.